Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Dulaglutide on Sexuality in Healthy Men (DESIRE)
NCT04687514Phase 2Completed
- Sponsor
- University Hospital Basel
- Start
- May 2021
- Primary completion
- Sep 2022
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dulaglutide in type 2 diabetes mellitus (T2DM) and obesity (2 arms), sponsored by University Hospital Basel. Primary endpoint: Massachusetts General Hospital - Sexual Functioning Questionnaire at 5 weeks. Started May 2021; status: completed.
02
Drugs
dulaglutide
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NCT04687514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04687514.